Skip to main content

Table 2 Univariate and multivariate analyses of risk factors for CR in patients with AEH and early EC

From: Prediction of complete regression in fertility-sparing patients with endometrial cancer and apical hyperplasia: the GLOBAL model in a large Chinese cohort

Variables

Univariate analysis

HR (95% CI)/P-value

Multivariate analysis

HR (95% CI)/P-value

Basic information

2.18 (1.21, 6.05) 0.014

2.35 (1.05, 5.27) 0.037

Characteristics

2.61 (1.33, 5.51) 0.006

3.78 (2.02, 279.71) 0.011

Blood pressure

2.35 (1.33, 5.71) 0.004

18.54 (1.08, 319.43) 0.045

Glucose metabolism

2.71 (1.54, 4.77) 0.001

12.54 (1.23, 127.98) 0.037

Lipid metabolism

0.76 (0.47, 1.21) 0.254

8.32 (1.35, 51.34) 0.021

Immunohistochemistry

2.68 (1.47, 4.90) 0.001

2.194 (1.10, 4.35) 0.025

Histological type

 AEH

1.0

1.0

 Early EC

0.54 (0.38, 0.78) 0.001

0.63 (0.43, 0.93) 0.019

Medication method

 Combined medicine

1.0

1.0

 Single medicine

0.40 (0.28, 0.57) < 0.001

0.46 (0.31, 0.68) 0.001

Maintenance treatment

 No

1.0

 

 Yes

1.08 (0.74, 1.58) 0.701

 
  1. AEH, apical endometrial hyperplasia; EC, endometrial cancer; CR, complete regression; MRS, metabolic risk score; BMI, body mass index; PCOS, polycystic ovary syndrome